Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...
Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...
Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...